Published in Medical Devices and Surgical Technology Week, March 19th, 2006
According to recent research from the United States, "This phase I study attempted to report the initial safety and efficacy results of transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using the new Amplatzer Membranous VSD Occluder (AGA Medical Corp., Golden Valley, Minnesota) in the U.S. The most common congenital heart disease is PmVSD. Surgical repair is widely accepted, but still carries a small...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week